Pedigree-based quantitative genetic analysis of interindividual variation in circulating levels of IGFBP-3

Journal of Bone and Mineral Metabolism

Volumn 20, Issue 3, 2002, Pages 156-163

  Pantsulaia, I A ^a   Trofimov, Svetlana ^a   Kobyliansky, Eugene ^a   Livshits, Gregory ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

BMD; IGFBP 3; Major gene; Segregation analysis

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; ESTRADIOL; TESTOSTERONE;

ADULT; AGED; ARTICLE; BONE; BONE DENSITY; CAUCASIAN; CONTROLLED STUDY; CORRELATION ANALYSIS; COVARIANCE; ETHNIC GROUP; FEMALE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PEDIGREE ANALYSIS; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SEGREGATION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ADOLESCENT; AGE; BIOLOGICAL MODEL; BLOOD; BODY HEIGHT; BODY WEIGHT; GENETICS; MIDDLE AGED; PEDIGREE; POSTMENOPAUSE; PREMENOPAUSE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; ESTRADIOL; FEMALE; GENOTYPE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; MIDDLE AGED; MODELS, GENETIC; MULTIVARIATE ANALYSIS; PEDIGREE; PHENOTYPE; POSTMENOPAUSE; PREMENOPAUSE; TESTOSTERONE; VARIATION (GENETICS);

EID: 0011013758     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007740200022     Document Type: Article

References (42)

1. Martel-Pelletier J, Di Battista JA, Lajeunesse D, Pelletier JP (1998) IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis. Inflamm Res 47:90-100
2. Johansson AG, Forslund A, Hambraeus L, Blum WF, Ljunghall S (1994) Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men. J Bone Miner Res 9:915-921
3. Canalis E, Rydziel S, Delany AM, Varghese S, Jeffrey JJ (1995) Insulin-like growth factors inhibit interstitial collagenase synthesis in bone cell cultures. Endocrinology 136:1348-1354
4. Kim JG, Shin CS, Choi YM, Moon SY, Kim SY, Lee JY (1999) The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60. Clin Endocrinol 51:301-307
5. Schmid C (1993) The regulation of osteoblast function by hormones and cytokines with special reference to insulin-like growth factors and their binding proteins. J Intern Med 234:535-542
6. Johansson A, Eriksen EF, Lindh E, Langdahl B, Blum WF, Lindahl A, Ljunggren O, Ljunghall S (1997) Reduced serum levels of the growth hormone-dependent insulin-like growth factor binding ptrotein and negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men. J Clin Endocrinol Metab 82:2795-2798
7. Mohan S, Baylink DJ (1996) Insulin-like growth (IGF)-binding proteins in serum: do they have additional roles besides modulating the endocrine IGF actions (editorial)? J Clin Endocrinol Metab 81:3817-3820
8. Rajaram S, Baylink DJ, Mohan S (1997) Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocrine Rev 18:801-831
9. Ferry RJ Jr, Cerri RW, Cohen P (1999) Insulin-like growth factor binding proteins: new proteins, new functions. Horm Res 51:53-67
10. Hwa V, Oh Y, Rosenfeld RG (1999) The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocrine Rev 20:761-787
11. Rosenfeld RG, Hwa V, Wilson E, Plymate SR, Oh Y (2000) The insulin-like growth factor-binding protein superfamily. Growth Horm IGF Res 10(Suppl):S16-17
12. Donahue LR, Hunter SJ, Sherblom AP, Rosen C (1990) Age-related changes in serum insulin-like growth factor binding proteins in women. J Clin Endocrinol Metab 71:575-579
13. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE (1994) The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, -2 and -3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol 41:85-93
14. Thiebaud D, Burckhardt P, Costanza M, Sloutskis D, Gilliard D, Quinodoz F, Jacquet AF, Burnand B (1997) Importance of albumin, 25(OH)-vitamin D and IGFBP-3 as risk factors in elderly women and men with hip fracture. Osteoporos Int 7:457-462
15. Sugimoto T, Nishiyama K, Kuribayashi F, Chihara K (1997) Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. J Bone Miner Res 12:1272-1279
16. Kassem M, Brixen K, Blum W, Mosekilde L, Eriksen EF (1994) No evidence for reduced spontaneous or growth hormone stimulated serum levels of insulin-like growth factor (IGF-1), IGF-II or IGF binding protein 3 in women with spinal osteoporosis. Eur J Endocrinol 131:150-155
17. Collins D, Woods A, Herd R, Blake G, Fogelman I, Wheeler M, Swaminathan R (1998) Insulin-like growth factor-I and bone mineral density. Bone 23:13-21
18. Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J, Toivanen L, Koskenvuo M, Leinonen P, Koistinen R, Seppala M (1996) Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 98:2612-2615
19. Deal C, Ma J, Wilkin F, Paquette J, Rozen F, Ge B, Hudson T, Stampfer M, Pollak M (2001) Novel promoter polymorphism in insulin-like growth factor binding protein-3: correlation with serum levels and interaction with known regulators. J Clin Endocrinol Metab 86:1274-1280
20. Jernstrom H, Deal Ch, Wilkin F, Chu W, Tao Y, Majeed N, Hudson T, Narod S, Pollak M (2001) Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-1 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev 10:377-384
21. Livshits G, Karasik D, Kobiliansky E (2002) Segregation analysis of the radiographic phalanges BMD and their age related changes. J Bone Miner Res 17:152-161
22. Livshits G, Karasik D, Pavlovsky OM, Kobiliansky E (1999) Segregation analysis reveals a major gene effect in compact and cancellous bone mineral density in two populations. Hum Biol 71:155-172
23. Sartoris DJ (1996) Quantitative bone mineral analysis. In: Resnick D (ed) Bone and Joint Imaging, 2nd edn. W.B. Saunders, Philadelphia, pp 154-164
24. Cosman F, Herrington B, Himmelstein S, Lindsay R (1991) Radiographic absorptiometry: a simple method for determination of bone mass. Osteoporosis Int 2:34-38
25. Falconer DS, Mackay TF (1996) Introduction to Quantitative Genetics, 4th edn. Longman, London, pp 122-143
26. Lange K, Weeks D, Boehnke M (1988) Program for pedigree analysis: Mendel, Fisher gen. Genet Epidemiol 5:471-472
27. Livshits G, Gerber LM (2001) Familial factors of blood pressure and adiposity covariation. Hypertension 37:928-935
28. Livshits G, Vainder M, Graff E, Blettner M, Schettler G, Brunner D (1997) Tel-Aviv-Heidelberg three generation offspring study: genetic and environmental sources of variation and covariation among plasma lipids, lipoproteins, and apolipoproteins. Am J Hum Biol 9:357-370
29. Otremski I, Karasik D, Livshits G (2000) Genetic variation and covariation of parathyroid hormone levels and bone density in the human population. Calcif Tissue Int 66:168-175
30. Elston RC, Stewart J (1971) A general model for the genetic analysis of pedigree data. Hum Hered 21:523-542
31. Beatty T (1997) Evolving methods in genetic epidemiology. I. Analysis of genetic and environmental factors in family studies. Epidem Rev 19:14-23
32. Ginsburg E, Livshits G (1999) Segregation analysis of quantitative traits. Ann Hum Biol 26:103-129
33. Spencer EM, Liu CC, Si EC, Howard GA (1991) In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats. Bone 12:21-26
34. Johansson AG, Lindh E, Ljunghall S (1992) Insulin-like growth factor I stimulates bone turnover in osteoporosis. Lancet 339: 1619
35. Corpas E, Harman SM, Blackman MR (1993) Human growth hormone and human aging. Endocr Rev 14:20-39
36. Tanaka H, Moriwake T, Matsuoka Y, Nakamura T, Seino Y (1998) Potential role of rhIGF-I/IGFBP-3 in maintaining skeletal mass in space. Bone 22:145S-147S
37. Stewart C, Rotwein P (1996) Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 76:1005-1026
38. Phillips LS, Pao CI, Villafuerte BC (1998) Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3. Prog Nucleic Acid Res Mol Biol 60:195-265
39. Platz EA, Pollak MN, Rimm EB, Majeed N, Tao Y, Willett WC, Giovannucci E (1999) Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. Cancer Epidemiol Biomarkers Prev 8:1107-1110
40. Tricoli JV, Winter DL, Hanlon AL, Raysor SL, Watkins-Bruner D, Pinover WH, Hanks GE (1999) Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer. Urology 54:178-182
41. Boonen S, Mohan S, Dequeker J, Aerssens J, Vanderschueren D, Verbeke G, Broos P, Bouillon R, Baylink DJ (1999) Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis. J Bone Miner Res 14:2150-2158
42. Janssen JA, Stolk RP, Pols HA, Grobbee DE, de Jong FH, Lamberts SW (1998) Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels. Clin Endocrinol (Oxf) 48:471-478